Zalcitabine
Zalcitabine is a potent nucleoside analogue reverse transcriptase inhibitor used in the treatment of HIV infection.
Product Specifications
CAS Number
[7481-89-2]
Product Name Alternative
2',3'-Dideoxycytidine; ddC; Dideoxycytidine
UNSPSC
12352005
Hazard Statement
H351
Target
HIV; Reverse Transcriptase
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/Zalcitabine.html
Purity
99.81
Solubility
DMSO : 62.5 mg/mL (ultrasonic) |H2O : ≥ 25 mg/mL
Smiles
OC[C@@H]1CC[C@H](N2C=CC(N)=NC2=O)O1
Molecular Formula
C9H13N3O3
Molecular Weight
211.22
Precautions
H351
References & Citations
[1]Adkins JC, et al. Zalcitabine. An update of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of HIV infection.Drugs. 1997 Jun;53 (6) :1054-80|[2]Jin MJ, et al. Interaction of zalcitabine with human organic anion transporter 1. Pharmazie. 2006 May;61 (5) :491-2.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
